Taku Kobayashi

59PUBLICATIONS
230CO-AUTHORS
Other Asian languages (excl. South-East Asian)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Clinical pharmacology and therapeuticsPredictive and prognostic markersAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (59)

|Jun 05, 2026
Distinct predictive factors for acute severe ulcerative colitis in East Asian and Western populations.

|May 20, 2026
Time to rethink washout periods in inflammatory bowel disease clinical trials: an international Delphi consensus.

|May 12, 2026
Asian Pacific Association of Gastroenterology (APAGE) Clinical Practice Guidelines on the Use of Small Molecules and IL-23 p19 Inhibitors in Ulcerative Colitis and Crohn's Disease.

|Mar 24, 2026
Personalized infliximab rescue therapy to maximize colectomy-free survival in patients with acute severe ulcerative colitis.

Emmanuel Niyigena, Yannick Hoffert, Waqqas Afif

|Mar 04, 2026
Mirikizumab four-year sustained and durable efficacy and safety in ulcerative colitis: Final findings from the LUCENT-3 open-label extension study.

Bruce E Sands, David B Clemow, Geert D'Haens

|Feb 09, 2026
Beyond the mucosa: intestinal ultrasound for post-endoscopic healing risk stratification in ulcerative colitis.

Shintaro Sagami, Katsuyoshi Matsuoka, Taku Kobayashi

Pageof 10

Frequent Collaborators

10 joint publications

Shintaro Sagami

8 joint publications

Tadakazu Hisamatsu

7 joint publications

Toshifumi Hibi

6 joint publications

Kunio Asonuma